Hologic [HOLX] vs Alcon [ALC] Detailed Stock Comparison

Hologic Inc.

NASDAQ
Loading...

Alcon Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Hologic Inc. wins in 12 metrics, Alcon Inc. wins in 7 metrics, with 0 ties. Hologic Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Hologic Inc. Alcon Inc. Better
P/E Ratio (TTM) 31.54 40.84 Hologic Inc.
Price-to-Book Ratio 3.23 2.07 Alcon Inc.
Debt-to-Equity Ratio 48.05 23.63 Alcon Inc.
PEG Ratio -3.92 26.11 Alcon Inc.
EV/EBITDA 12.68 21.16 Hologic Inc.
Profit Margin (TTM) 13.18% 11.28% Hologic Inc.
Operating Margin (TTM) 22.99% 13.30% Hologic Inc.
EBITDA Margin (TTM) 22.99% 13.30% Hologic Inc.
Return on Equity 10.86% 5.23% Hologic Inc.
Return on Assets (TTM) 7.43% 2.74% Hologic Inc.
Free Cash Flow (TTM) $904.70M $1.41B Alcon Inc.
1-Year Return 31.39% -22.45% Hologic Inc.
Price-to-Sales Ratio (TTM) 4.11 4.62 Hologic Inc.
Enterprise Value $17.12B $49.36B Alcon Inc.
EV/Revenue Ratio 4.15 4.97 Hologic Inc.
Gross Profit Margin (TTM) 55.96% 55.92% Hologic Inc.
Revenue per Share (TTM) $18 $20 Alcon Inc.
Earnings per Share (Diluted) $2.41 $2.25 Hologic Inc.
Beta (Stock Volatility) 0.70 0.70 Alcon Inc.
Short % of Float 3.66% N/A N/A

Hologic Inc. vs Alcon Inc. Stock Performance Analysis

Loading Price Chart...

HOLX
ALC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Hologic Inc.0.00%0.56%0.56%1.40%12.23%1.94%
Alcon Inc.-0.84%0.27%4.16%-14.78%-16.29%-14.57%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Hologic Inc.31.39%-9.66%-0.85%110.15%246.29%206.74%
Alcon Inc.-22.45%-17.74%-4.83%22.82%22.82%22.82%

Performance & Financial Health Analysis: Hologic Inc. vs Alcon Inc.

MetricHOLXALC
Market Information
Market Cap i$16.97B$45.84B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i12,273,0851,498,680
90 Day Avg. Volume i6,282,6251,604,603
Last Close$76.01$66.29
52 Week Range$51.90 - $76.07$61.83 - $92.55
% from 52W High-0.08%-28.37%
All-Time High$87.88 (May 01, 2023)$101.10 (Sep 09, 2024)
% from All-Time High-13.51%-34.43%
Growth Metrics
Quarterly Revenue Growth0.03%0.01%
Quarterly Earnings Growth-0.11%0.41%
Financial Health
Profit Margin (TTM) i0.13%0.11%
Operating Margin (TTM) i0.23%0.13%
Return on Equity (TTM) i0.11%0.05%
Debt to Equity (MRQ) i48.0523.63
Cash & Liquidity
Book Value per Share (MRQ)$23.51$44.39
Cash per Share (MRQ)$10.60$2.85
Operating Cash Flow (TTM) i$1.10B$2.12B
Levered Free Cash Flow (TTM) i$848.61M$1.18B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: Hologic Inc. vs Alcon Inc.

MetricHOLX (Apr 19, 2026)ALC (Jul 26, 2025)
Price Ratios
P/E Ratio (TTM) i31.5440.84
Forward P/E i15.6426.11
PEG Ratio i-3.9226.11
Price to Sales (TTM) i4.114.62
Price to Book (MRQ) i3.232.07
Market Capitalization
Market Capitalization i$16.97B$45.84B
Enterprise Value i$17.12B$49.36B
Enterprise Value Metrics
Enterprise to Revenue i4.154.97
Enterprise to EBITDA i12.6821.16
Risk & Other Metrics
Beta i0.700.70
Book Value per Share (MRQ) i$23.51$44.39

Financial Statements Comparison: Hologic Inc. vs Alcon Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricHOLX (2025)ALC (2024)
Revenue/Sales i4.10B9.91B
Cost of Goods Sold i1.98B4.40B
COGS % of Revenue i48.4%44.4%
Gross Profit i2.12B5.51B
Gross Margin i51.6%55.6%
Research & Development i248.20M876.00M
Operating Income (EBIT) i785.40M1.41B
Operating Margin i19.2%14.3%
EBITDA i1.17B2.71B
EBITDA Margin i28.5%27.3%
Pre-Tax Income i681.20M1.26B
Pre-Tax Income % of Revenue i16.6%12.7%
Income Tax i115.50M238.00M
Income Tax % of Revenue i2.8%2.4%
Net Income (Profit) i565.70M1.02B
Profit Margin i13.8%10.3%

Balance Sheet & Liquidity Metrics

MetricHOLX (2025)ALC (2024)
Cash & Equivalents i1.96B1.68B
Total Current Assets i3.67B6.31B
Total Current Assets % of Revenue i89.5%63.7%
Total Current Liabilities i977.20M2.28B
Total Current Liabilities % of Revenue i23.8%23.0%
Long-Term Debt i2.59B4.97B
Long-Term Debt % of Revenue i63.2%50.1%
Total Shareholders Equity i5.05B21.55B
Retained Earnings i3.41BN/A
Retained Earnings % of Revenue i83.2%0.0%
Property, Plant & Equipment i1.07B36.00M

Cash Flow Statement Comparison

MetricHOLX (2025)ALC (2024)
Operating Cash Flow i831.50M2.50B
Operating Cash Flow % of Revenue i20.3%25.2%
Capital Expenditures i-78.20M-473.00M
Free Cash Flow i904.70M1.41B
FCF Margin i22.1%14.2%
Debt Repayment i-1.20B-196.00M
Common Stock Repurchase i-752.90MN/A

Short Interest & Institutional Ownership Analysis

MetricHOLXALC
Shares Short i7.10M6.89M
Short Ratio i2.784.54
Short % of Float i3.66%N/A
Shares Outstanding i223.07M494.62M
Float Shares i221.21M494.60M
% Held by Insiders i0.84%0.13%
% Held by Institutions i96.52%68.80%
% Held by Public i2.64%31.07%

Dividend Analysis & Yield Comparison: Hologic Inc. vs Alcon Inc.

MetricHOLXALC
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$0.17
3-Year Avg Dividend Yield iN/A0.30%
3-Year Total Dividends iN/A$0.50
Ex-Dividend DateN/AMay 14, 2024